Showing results (951-960 of 1,842) with videos related to

Sort By:
Pageof 185
ESMO Open|May 9, 2025
Impact of whole genome sequencing on the care pathway for patients with cancer of unknown primaryE Droogers, Y Teunissen, A J van Puffelen, et al.
ESMO Open|August 21, 2025
Improving chemotherapy-induced peripheral neuropathy in cancer patients using a combined qigong and self-administered acupressure intervention: a randomized controlled trialD S T Cheung, W F Yeung, P H Chau, et al.
ESMO Open|August 21, 2025
The landscape of conventional and artificial intelligence-based clinical prediction models in non-small-cell lung cancer: from development to real-world validationH R Howard, M Hasanova, A Tiwari, et al.
ESMO Open|January 30, 2026
Prediction of survival and outcomes with depth of response at 6 months in metastatic non-small-cell lung cancer patients treated with chemotherapy and immunotherapy combination: SPORE trialF Moinard-Butot, J-B Barbe-Richaud, J Lasvergnas, et al.
ESMO Open|February 13, 2026
Neoadjuvant immune checkpoint inhibitors for localized dMMR/MSI-H gastric cancer: a meta-analysisW K Schwengber, R A Pereira, L F Leite da Silva, et al.
ESMO Open|February 6, 2026
Prognostic nomogram for patients with HER2-negative metastatic gastric cancer receiving first-line PD-1 blockadeB Fu, M Zhang, T Fang, et al.
ESMO Open|February 6, 2026
Paclitaxel plus cetuximab for the treatment of R/M SCCHN after first-line pembrolizumab failure: primary analysis from the PaceAce trialT Fuereder, K Klinghammer, D Hahn, et al.
ESMO Open|January 28, 2026
Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancerK L Jhaveri, N M Iyengar, N C Turner, et al.
ESMO Open|March 26, 2025
Advances in individualization of systemic treatment for locoregionally advanced nasopharyngeal carcinoma: a systematic reviewP Blanchard, F De Felice, M L K Chua
ESMO Open|March 22, 2025
Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assayW Janni, B Rack, T W P Friedl, et al.
Pageof 185